State of plasma hemostasis in patients with hypertension in combination with non-alcoholic fatty liver disease

N. Bazhenova


Background. Among liver diseases, non-alcoholic fatty liver disease (NAFLD) is the most common. NAFLD is an independent risk factor for the development and progression of cardiovascular diseases. Objective. To determine the state of the anticoagulant, fibrinolytic and coagulation hemostasis in patients with hypertension and concomitant non-alcoholic fatty liver disease in the presence of obesity. Materials and methods. 150 patients (64 men and 86 women) were examined. Groups of patients: I - 50 patients with HT stage 2, II - 48 patients with NAFLD without HT, group III - 52 patients who had HT stage 2 with concomitant NAFLD. Results. PT value decrease in the NAFLD group by 12.2% (p<0.01). The level of TT is reduced by 16.2% (p<0.001) in the group with NAFLD. APTT decreases in patients with NAFLD by 13.3% (p<0.001) and when combined with NAFLD with hypertension by 13.6% (p<0.05). Fibrinogen increases in the HT group by 31.5% (p<0.001), and in the NAFLD group combined with HT - by 39.8% (p<0.001). SFMK levels significantly increase in all groups of patients: in patients with hypertension - 4.9 times (p<0.001), with NAFLD - 3 times (p<0.001), in the NAFLD+HT group - 5.3 times (p<0.001). There is a decrease in AT III by 16.4% in both the HT group (p<0.01) and the NAFLD group (p<0.01), combined pathology leads to more significant inhibition AT III - by 20.3% (p<0.001). HDF increases in the HT group - by 47% (p<0.001), in the NAFLD group - by 78% (p<0.001), in the NAFLD + HT group - 2.4 times (p<0.001).). Conclusions. In hypertension combined with NAFLD, depletion of anticoagulant and fibrinolytic potential against the background of activation of coagulant hemostasis, indicate the presence of prothrombogenic changes.


non-alcoholic fatty liver disease, hemostasis, hypertension, anticoagulant, fibrinolysis, coagulation

Full Text:



Byrne, C. D., & Targher, G. (2015). NAFLD: A multisystem disease. Journal of Hepatology, 62(S1), S47–S64.

Davalos, D., & Akassoglou, K. (2012). Fibrinogen as a key regulator of inflammation in disease. Seminars in Immunopathology, 34(1), 43–62.

Elazab Elged, A. A., El-Gamal, R. A., Bastawy, S., & Saeed, M. (2016). Soluble fibrin monomer complex assay enhances early and accurate diagnosis of acute myocardial infarction. International Journal of Clinical and Experimental Pathology, 9(5), 5801–5809.

Fargion, S., Porzio, M., & Fracanzani, A. L. (2014). Nonalcoholic fatty liver disease and vascular disease: state-of-the-art. World Journal of Gastroenterology, 20(37), 13306–13324.

Hall, J. E., do Carmo, J. M., da Silva, A. A., Wang, Z., & Hall, M. E. (2015). Obesity-Induced Hypertension: Interaction of Neurohumoral and Renal Mechanisms. Circulation Research, 116(6), 991–1006.

Hassan, F. M., & Merghani, M. M. (2016). Coagulation Disturbance among Essential Hypertensive and Diabetes Mellitus Type II Patients-Khartoum State Merghani MM. Bangladesh Journal of Medical Science (Vol. 15).

JiskaniS, A., Memon, S., & Naseem, L. (2017). Prothrombin time (PT), activated partial thromboplastin time (APTT) and international normalized ratio (INR) as predictive factors of coagulopathy in newly diagnosed hypertensive patients. Hematology & Transfusion International Journal, 4(3), 1–0.

Junker, R., Heinrich, J., Schulte, H., Erren, M., & Assmann, G. (1998). Hemostasis in normotensive and hypertensive men: results of the PROCAM study. The prospective cardiovascular Münster study. Journal of Hypertension, 16(7), 917–923. Retrieved from

Lallukka, S., Orho-Melander, M., Lundbom, N., Olkkonen, V. M., & Yki-Järvinen, H. (2016). Activity of Coagulation Factors IX and XIII and Fibrinogen are Increased in “Obese Non-Alcoholic Fatty Liver Disease” but not in “PNPLA3 Non-Alcoholic Fatty Liver Disease.” Journal of Hepatology, 64(2), S499.

Lip, G. Y., Blann, A. D., Jones, A. F., Lip, P. L., & Beevers, D. G. (1997). Relation of endothelium, thrombogenesis, and hemorheology in systemic hypertension to ethnicity and left ventricular hypertrophy. The American Journal of Cardiology, 80(12), 1566–1571. Retrieved from

Makris, T. K., Tsoukala, C., Krespi, P., Hatzizacharias, A., Gialeraki, A., Papargyriou, J., … Mandalaki, T. (1997). Haemostasis balance disorders in patients with essential hypertension. Thrombosis Research, 88(2), 99–107. Retrieved from

Mancia, G., Fagard, R., Narkiewicz, K., Redon, J., Zanchetti, A., Böhm, M., … Wood, D. A. (2013). 2013 ESH/ESC guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). European Heart Journal, 34(28), 2159–2219.

Nnenna Adaeze, N., Uchenna Emeribe, A., Abdullahi Nasiru, I., Babayo, A., & Uko, E. K. (2014). Evaluation of Prothrombin Time and Activated Partial Thromboplastin Time in Hypertensive Patients Attending a Tertiary Hospital in Calabar, Nigeria. Advances in Hematology, 2014, 1–7.

Poulter, N. R., Prabhakaran, D., & Caulfield, M. (2015). Hypertension. The Lancet, 386(9995), 801–812.

Repetto, O., & De Re, V. (2017). Coagulation and fibrinolysis in gastric cancer. Annals of the New York Academy of Sciences, 1404(1), 27–48.

Rinella, M. E. (2015). Nonalcoholic Fatty Liver Disease. JAMA, 313(22), 2263.

Stine, J. G., Intagliata, N., Northup, P. G., & Caldwell, S. H. (2017). Nonalcoholic Fatty Liver Disease, Portal Vein Thrombosis and Coagulation. Transplantation, 101(8), e281–e282.

Tripodi, A., Fracanzani, A. L., Primignani, M., Chantarangkul, V., Clerici, M., Mannucci, P. M., … Fargion, S. (2014). Procoagulant imbalance in patients with non-alcoholic fatty liver disease. Journal of Hepatology, 61(1), 148–154.

Woodward, M., Lowe, G. D., Rumley, A., Tunstall-Pedoe, H., Philippou, H., Lane, D. A., & Morrison, C. E. (1997). Epidemiology of coagulation factors, inhibitors and activation markers: The Third Glasgow MONICA Survey. II. Relationships to cardiovascular risk factors and prevalent cardiovascular disease. British Journal of Haematology, 97(4), 785–797. Retrieved from



  • There are currently no refbacks.

Copyright (c) 2018 © The Author (s) 2018

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Journal of Education, Health and Sport formerly Journal of Health Sciences

Declaration on the original version.

Editors indicates that the main version of the magazine is to issue a "electronic".

The journal has had 5 points in Ministry of Science and Higher Education parametric evaluation. § 8. 2) and § 12. 1. 2) 22.02.2019.

1223 Journal of Education, Health and Sport eISSN 2391-8306 7

ISSN 2391-8306 formerly ISSN: 1429-9623 / 2300-665X

Archives 2011 - 2014

PBN 2011 - 2014

POL-index 2011 - 2014

BASE 2011 - 2014

Indexed in Bases, Bazy indeksacyjne: ERIH Plus, Worldcat, PBN/POL-Index, ICI Journals Master List, Directory of Open Access Journals (DOAJ), ZBD, Ulrich's periodicals, Google Scholar, Polska Bibliografia Lekarska

US NLM = 101679844

101679844 - NLM Catalog Result - NCBI

Find a library that holds this journal:

Journal Language(s): English 

PBN Poland



Redaction, Publisher and Editorial Office

Instytut Kultury Fizycznej Uniwersytet Kazimierza Wielkiego w Bydgoszczy, Institute of Physical Education Kazimierz Wielki University in Bydgoszcz, Poland 85-091 Bydgoszcz ul. Sportowa 2 Copyright by Instytut Kultury Fizycznej UKW w Bydgoszczy  Open Access ISSN 2391-8306 formerly ISSN: 1429-9623 / 2300-665X

The journal has been approved for inclusion in ERIH PLUS.

The ERIH PLUS listing of the journal is available at

SIC Science citation index (calculated on the basis of TCI and Page Rank) 0

Russian Impact factor 0.16

Indexed in Index Copernicus Journals Master List.,p24782242,3.html

ICV 2018 = 95.95 ICV 2017 = 91.30 ICV 2016 = 84.69 ICV 2015 = 93.34 ICV 2014 = 89.51 Standardized Value: 8.27 ICV 2013: 7.32 ICV 2012: 6.41 ICV 20115.48

The InfoBase Index IBI Factor for the year 2015 is 3.56 in InfoBase


Universal Impact Factor 1.78 for year 2012. (

Indexed in Polish Scholarly Bibliography (PBN) (PBN Polska Bibliografia Naukowa) (

is a portal of the Polish Ministry of Science and Higher Education, collecting information on publications of Polish scientists and on Polish and foreign scholarly journals. Polish Scholarly Bibliograhpy is a part of POL-on - System of Information on Higher Education. It is operated by the Interdisciplinary Centre for Mathematical and Computational Modelling, University of Warsaw.

Indexed in Russian Sciences Index Российский индекс научного цитирования (РИНЦ)

Indexed in Arianta Polish scientific and professional electronic journals Aneta Drabek i Arkadiusz Pulikowski